| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/10/2004 | WO2004047623A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047615A2 Hemiasterlin affinity probes and their uses |
| 06/10/2004 | WO2004047614A2 Methods, biosensors and kits for detecting and identifying fungi |
| 06/10/2004 | WO2004047612A2 Methods of therapy and diagnosis |
| 06/10/2004 | WO2004047514A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004035092A3 Use of an agent modulating cofilin expresion or activity for the treatment of inflammatory diseases |
| 06/10/2004 | WO2004034055A3 Method for detecting and limiting breast carcinoma risk by a micronucleus test of binuclear cells |
| 06/10/2004 | WO2004031723A3 Method and apparatus for hemostasis and blood management |
| 06/10/2004 | WO2004030721A3 Fluid collecting device, methods of production and uses thereof |
| 06/10/2004 | WO2004029576A3 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 06/10/2004 | WO2004027388A3 Novel green and orange fluorescent labels and their uses |
| 06/10/2004 | WO2004027372A3 Method for diagnosing rhabdomyosarcoma and pharmaceutical compositions for the treatment and/or prevention of rhabdomyosarcoma |
| 06/10/2004 | WO2004025562B1 Method and apparatus for labelling using diffraction grating-based encoded optical identification elements |
| 06/10/2004 | WO2004025560B1 Assay stick comprising coded microbeads |
| 06/10/2004 | WO2004018996A3 High-throughput assay of hematopoietic stem and progenitor cell proliferation |
| 06/10/2004 | WO2004018704A3 Point source biological agent detection system |
| 06/10/2004 | WO2004017810A3 Tumor specific oligosaccharide epitopes and use thereof |
| 06/10/2004 | WO2004017374A3 Reading of fluorescent arrays |
| 06/10/2004 | WO2004016102A3 A rapid method for predicting tomato paste consistency |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2004012847A8 Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers |
| 06/10/2004 | WO2004011911A3 Use of dye to distinguish salt and protein crystals under microcrystallization conditions |
| 06/10/2004 | WO2004011900A3 Detecting receptor oligomerization |
| 06/10/2004 | WO2004011669A3 Apparatus and methods for binding molecules and cells |
| 06/10/2004 | WO2004011221A3 Method and apparatus for determining an angle of gyration and/or the pressure in a gyratory compactor |
| 06/10/2004 | WO2004010928A3 Steroid modulators in the treatment of peripheral nerve sheath tumors |
| 06/10/2004 | WO2004004698A3 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/10/2004 | WO2004001425A3 Mhc class ii haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins |
| 06/10/2004 | WO2004000995A3 Methods, probes, and accessory molecules for detecting single nucleotide polymorphisms |
| 06/10/2004 | WO2003102140A3 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 06/10/2004 | WO2003095475A8 Peptide compounds and their use as protease substrates |
| 06/10/2004 | WO2003089915A3 Method for restoring the sensitivity, speed or stability of a gas-sensitive material |
| 06/10/2004 | WO2003089902A3 Displacement assay for detection of small molecules |
| 06/10/2004 | WO2003089586A3 Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye |
| 06/10/2004 | WO2003089571A3 Ehrlichia canis genes and vaccines |
| 06/10/2004 | WO2003087158A3 Regulation of human transient receptor potential channel |
| 06/10/2004 | WO2003083431A9 Pressure activated calibration system for chemical sensors |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003082214A3 Human metabolic models and methods |
| 06/10/2004 | WO2003077841A9 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases |
| 06/10/2004 | WO2003076588A8 Multiplexed cell transfection using coded carriers |
| 06/10/2004 | WO2003071140A3 Cell viability detection using electrical measurements |
| 06/10/2004 | WO2003068935A3 Methods of therapy and diagnosis |
| 06/10/2004 | WO2003067215A3 Automatic threshold setting and baseline determination for real-time pcr |
| 06/10/2004 | WO2003067212A3 Methods and reagents for conducting multiplexed assays of multiple analytes |
| 06/10/2004 | WO2003037258A3 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 06/10/2004 | WO2003035049A3 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections |
| 06/10/2004 | WO2003013603A8 Modulators of p-selectin glycoprotein ligand 1 |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | WO2002095399A3 Method for certifying chondrocytes for use in cartilage regeneration |
| 06/10/2004 | WO2002090600A3 A method for regulating immune function in primates using the foxp3 protein |
| 06/10/2004 | WO2002082078A3 Activated enzyme-linked detection systems for detecting and quantifying nucleid acids, antigens antibodies and other analytes |
| 06/10/2004 | WO2002059144A8 Differential labeling for quantitative analysis of complex protein mixtures |
| 06/10/2004 | WO2002054326A3 Method for organizing and depicting biological elements |
| 06/10/2004 | US20040111769 Sugar beet genes involved in stress tolerance |
| 06/10/2004 | US20040111768 Transcription factor stress-related proteins and methods of use in plants |
| 06/10/2004 | US20040111766 for use as therapeutic agent or additive for ingestible food/feed |
| 06/10/2004 | US20040111758 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 06/10/2004 | US20040111674 Graphical viewer for biomolecular sequence data |
| 06/10/2004 | US20040111228 System for analyzing compound structure |
| 06/10/2004 | US20040111221 Oligonucleotide probes for genosensor chips |
| 06/10/2004 | US20040111017 Mass transport limited in vivo analyte sensor |
| 06/10/2004 | US20040110941 by cloning, amplifying and expressing DNA sequences using polymerase chain reaction; for therapy, diagnosis or catalysis; solid phase synthesis |
| 06/10/2004 | US20040110934 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 06/10/2004 | US20040110925 Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
| 06/10/2004 | US20040110924 Identification and characterization of multiple splice variants of the kappa3-related opioid receptor (KOR-3) gene |
| 06/10/2004 | US20040110921 Comprises chordin-like polypeptide fo diagnosis, pre vention and treatment of bone and cancer disorders; gene therapy; antitumor agents |
| 06/10/2004 | US20040110734 Combinations for the treatment of inflammatory disorders |
| 06/10/2004 | US20040110723 Modified psma ligands and uses related thereto |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110712 Methods for treating patients and identifying therapeutics |
| 06/10/2004 | US20040110710 Methods of reducing ischemic injury |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110690 Transporter peptide capable of translocating across biological membrane of pancreatic B-cells, hepatocytes, colon cells, muscle cells and/or lung cells; drug delivery; biochemical conjugation |
| 06/10/2004 | US20040110684 Genetically engineered caveolin-; antiischemic, antitumor, and wound healing agents; cardiovascular and brain disorders |
| 06/10/2004 | US20040110678 Novel drug delivery system |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110676 Administering huntington protein or biologically-active fragment or variant to treat Huntington's, Alzheimer's , Parkinson's , amyotrophic lateral sclerosis, multiple sclerosis, and other neurodegenerative diseases |
| 06/10/2004 | US20040110674 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 06/10/2004 | US20040110668 Nucleic acid sequences differentially expressed in cancer tissue |
| 06/10/2004 | US20040110663 Hedgehog antagonists, methods and uses related thereto |
| 06/10/2004 | US20040110307 System and method for obtaining and maintaining high-resistance seals in patch clamp recordings |
| 06/10/2004 | US20040110306 Using flame ionization detector to detect and quantify concentration of volatile organic compounds (VOC) in emissions; pollution control; air pollution |
| 06/10/2004 | US20040110305 Method of mixing a sample with a reagent in a chemistry |
| 06/10/2004 | US20040110303 Artificial receptors, building blocks, and methods |
| 06/10/2004 | US20040110300 Thermal sensor |
| 06/10/2004 | US20040110299 Array comprising silca gel or porous plastic resins for detecting volatile organic compounds in ground water; pollution control |
| 06/10/2004 | US20040110289 Obtaining liver cells suspension via proteolytic digestion followed by density gradient centrifugation; liver regeneration and transplantation therapy |
| 06/10/2004 | US20040110284 Monoclonal antibody for use in passive immunization against poisoning/intoxication by botulin toxins |
| 06/10/2004 | US20040110278 Device for improving mixing efficiency and uniformity of substances reacting with probes immobilized on arrays |
| 06/10/2004 | US20040110277 Biosensor apparatus comprising biomolecule receptors for use as tool in genome analysis |
| 06/10/2004 | US20040110276 Surface treatment |
| 06/10/2004 | US20040110272 Biochemical vessel |
| 06/10/2004 | US20040110268 Attenuated Pasteurellaceae virulence genes are identified and used to screen bactericides and produce vaccines which prevent infection |
| 06/10/2004 | US20040110263 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 06/10/2004 | US20040110253 used in studying T cells and their antigenic targets in autoimmunity, hypersensitivity, and cancer; for drug screening; genetic engineering |
| 06/10/2004 | US20040110250 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 06/10/2004 | US20040110246 By measuring a D-mannose concentration and a glucose concentration; comprises a glucose eliminator/enzyme |
| 06/10/2004 | US20040110245 uses energy transfer phenomenon in a detection system for the measurement of the concentration of a materials; solid phase synthesis; kits; for clinical diagnosis, food/environmental hygiene |
| 06/10/2004 | US20040110244 Methods for diagnosing drug-resistant cancer cells or for identifying chemotherapeutic agents by measuring anomalous intracellular ion and/or second messenger dynamics |